The transcriptome of a complete episode of acute otitis media
暂无分享,去创建一个
M. Hernandez | A. Leichtle | A. Ryan | N. Webster | S. Wasserman | K. Pak
[1] A. Kurabi,et al. The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media , 2015, Innate immunity.
[2] A. Kurabi,et al. A Mouse Model of Otitis Media Identifies HB-EGF as a Mediator of Inflammation-Induced Mucosal Proliferation , 2014, PloS one.
[3] D. Preciado,et al. NTHi induction of Cxcl2 and middle ear mucosal metaplasia in mice , 2013, The Laryngoscope.
[4] J. B. Kempton,et al. Otitis Media Impacts Hundreds of Mouse Middle and Inner Ear Genes , 2013, PloS one.
[5] F. Orji. A Survey of the Burden of Management of Chronic Suppurative Otitis Media in a Developing Country , 2013, Annals of medical and health sciences research.
[6] D. Weeks,et al. A Genome-Wide Association Study of Chronic Otitis Media with Effusion and Recurrent Otitis Media Identifies a Novel Susceptibility Locus on Chromosome 2 , 2013, Journal of the Association for Research in Otolaryngology.
[7] M. Bhutta,et al. What Have We Learned from Murine Models of Otitis Media? , 2013, Current Allergy and Asthma Reports.
[8] A. Kurabi,et al. Ecrg4 Attenuates the Inflammatory Proliferative Response of Mucosal Epithelial Cells to Infection , 2013, PloS one.
[9] F. Ceciliani,et al. Α₁-acid glycoprotein modulates phagocytosis and killing of Escherichia coli by bovine polymorphonuclear leucocytes and monocytes. , 2013, Veterinary journal.
[10] T. Akaike,et al. S‐nitrosated α‐1‐acid glycoprotein kills drug‐resistant bacteria and aids survival in sepsis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] N. Warrington,et al. Genome-Wide Association Study to Identify the Genetic Determinants of Otitis Media Susceptibility in Childhood , 2012, PloS one.
[12] G. Ligresti,et al. The Acute Phase Reactant Orosomucoid-1 Is a Bimodal Regulator of Angiogenesis with Time- and Context-Dependent Inhibitory and Stimulatory Properties , 2012, PloS one.
[13] James T. Elder,et al. HEPARIN-BINDING EGF-LIKE GROWTH FACTOR PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN KERATINOCYTES , 2012, The Journal of investigative dermatology.
[14] P. Zipfel,et al. Haemophilus influenzae Uses the Surface Protein E To Acquire Human Plasminogen and To Evade Innate Immunity , 2012, The Journal of Immunology.
[15] Jeffrey T. Leek,et al. A computationally efficient modular optimal discovery procedure , 2011, Bioinform..
[16] R. Arsenescu,et al. Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis , 2010, BMC gastroenterology.
[17] G. Koh,et al. Adipocytokine Orosomucoid Integrates Inflammatory and Metabolic Signals to Preserve Energy Homeostasis by Resolving Immoderate Inflammation* , 2010, The Journal of Biological Chemistry.
[18] M. Hernandez,et al. CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF−/− mice , 2010, The Journal of Immunology.
[19] M. Hernandez,et al. CC Chemokine Ligand 3 Overcomes the Bacteriocidal and Phagocytic Defect of Macrophages and Hastens Recovery from Experimental Otitis Media in TNF−/− Mice , 2010, The Journal of Immunology.
[20] Steve D. M. Brown,et al. 13-P138 Regulation of TGF beta signalling by Fbxo11, the gene mutated in the Jeff Otitis Media mouse mutant , 2009, Mechanisms of Development.
[21] M. Hernandez,et al. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media , 2009, Innate immunity.
[22] Steve D. M. Brown,et al. Regulation of TGF-β signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant , 2009, PathoGenetics.
[23] A. Pozzi,et al. Soluble HB-EGF induces epithelial-to-mesenchymal transition in inner medullary collecting duct cells by upregulating Snail-2. , 2009, American journal of physiology. Renal physiology.
[24] M. Hernandez,et al. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. , 2008, The Journal of infectious diseases.
[25] J. Houwing-Duistermaat,et al. The 4G/4G Plasminogen Activator Inhibitor-1 Genotype Is Associated With Frequent Recurrence of Acute Otitis Media , 2007, Pediatrics.
[26] J. Ting,et al. CATERPILLER (NLR) family members as positive and negative regulators of inflammatory responses. , 2007, Proceedings of the American Thoracic Society.
[27] P. Mannon,et al. The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.
[28] A. Ryan,et al. Jun N-Terminal Protein Kinase Enhances Middle Ear Mucosal Proliferation during Bacterial Otitis Media , 2007, Infection and Immunity.
[29] S. Badve,et al. NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 , 2007, Oncogene.
[30] R. Matalon,et al. Association of Proinflammatory Cytokine Gene Polymorphisms With Susceptibility to Otitis Media , 2006, Pediatrics.
[31] Steve D. M. Brown,et al. A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse. , 2006, Human molecular genetics.
[32] Steve D. M. Brown,et al. Mutation at the Evi1 Locus in Junbo Mice Causes Susceptibility to Otitis Media , 2006, PLoS genetics.
[33] J. Raynes,et al. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. , 2006, Blood.
[34] Tilman Brummer,et al. Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1 , 2006, Nature Immunology.
[35] H. Sudhoff,et al. Role of mast cells in otitis media. , 2005, The Journal of allergy and clinical immunology.
[36] P. Hebda,et al. Gene expression profiles of early pneumococcal otitis media in the rat. , 2005, International journal of pediatric otorhinolaryngology.
[37] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] T. Lehman,et al. Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis , 2005, Current opinion in rheumatology.
[39] A. Ryan,et al. The role of Fas-mediated apoptosis in otitis media: Observations in the lpr/lpr mouse , 2005, Hearing Research.
[40] Trey Ideker,et al. VAMPIRE microarray suite: a web-based platform for the interpretation of gene expression data , 2005, Nucleic Acids Res..
[41] C. Dinarello. Blocking IL-1 in systemic inflammation , 2005, The Journal of experimental medicine.
[42] S. Akira,et al. Toll-like receptor downstream signaling , 2004, Arthritis research & therapy.
[43] A. Netzer,et al. Does Otitis Media in Early Childhood Affect Reading Performance in Later School Years? , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[44] A. Gordin,et al. Does Otitis Media in Early Childhood Affect Reading Performance in Later School Years? , 2004 .
[45] A. Ryan,et al. Effects of amoxicillin on cytokine and osteocalcin expression in bone tissue during experimental acute otitis media. , 2004, Cytokine.
[46] A. Ryan,et al. A mouse model for acute otitis media , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[47] R. Rosenfeld,et al. Evidence-Based Otitis Media , 2003 .
[48] Harry Greenberg,et al. Novel generations of influenza vaccines. , 2003, Vaccine.
[49] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[50] Jacques Corbeil,et al. Statistical analysis of high-density oligonucleotide arrays: a multiplicative noise model , 2002, Bioinform..
[51] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[52] D. Bagger-sjöbäck,et al. Detection and localization of interleukin-6 in the rat middle ear during experimental acute otitis media, using mRNA in situ hybridization and immunohistochemistry. , 2001, International journal of pediatric otorhinolaryngology.
[53] J. Klein,et al. The burden of otitis media. , 2000, Vaccine.
[54] M. Vaneechoutte,et al. Turnover of Haemophilus influenzae isolates in otitis-prone children. , 2000, Acta oto-rhino-laryngologica Belgica.
[55] I. Wallace,et al. Early Otitis Media and Phonological Development at Age 2 Years , 1996, The Laryngoscope.
[56] A. Mantovani,et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.
[57] A. Cerami,et al. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[58] S. Friel-Patti,et al. Language delay in infants associated with middle ear disease and mild, fluctuating hearing impairment , 1982, Pediatric infectious disease.
[59] W. Doyle,et al. Recurrent pneumococcal otitis media in the chinchilla. A longitudinal study. , 1981, Archives of otolaryngology.
[60] A. Chaudhary,et al. Induction of cytokines and chemokines by Toll-like receptor signaling: strategies for control of inflammation. , 2010, Critical reviews in immunology.
[61] P. Moingeon,et al. Mucosal immunization application to allergic disease: sublingual immunotherapy. , 2007, Allergy and asthma proceedings.
[62] E. Sanders,et al. Immunological Status in the Aetiology of Recurrent Otitis Media with Effusion: Serum Immunoglobulin Levels, Functional Mannose-Binding Lectin and Fc Receptor Polymorphisms for IgG , 2005, Journal of Clinical Immunology.
[63] P. Morris,et al. Chronic suppurative otitis media Burden of Illness and Management Options , 2004 .
[64] C. Infante-Rivard,et al. Otitis media in children: frequency, risk factors, and research avenues. , 1993, Epidemiologic reviews.